Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Poveda

Showing results (81-90 of 149) with videos related to

Pageof 15
Sort By:
Antiviral Therapy|June 28, 2013
Very late relapse after discontinuation of antiviral therapy for chronic hepatitis CVincent Soriano, Eugenia Vispo, Carmen de Mendoza, et al.
Open Forum Infectious Diseases|September 8, 2018
High Prevalence of Late-Stage Disease in Newly Diagnosed Human Immunodeficiency Virus Patients in Sierra LeoneGeorge A Yendewa, Eva Poveda, Sulaiman Lakoh, et al.
HIV Medicine|March 2, 2022
Predictors of low-level HIV viraemia and virological failure in the era of integrase inhibitors: A Spanish nationwide cohortHortensia Álvarez, Marta Rava, Cristina Martínez, et al.
Antiviral Research|November 14, 2012
The changing face of hepatitis C in the new era of direct-acting antiviralsVincent Soriano, Pablo Labarga, Jose V Fernández-Montero, et al.
The Journal of Antimicrobial Chemotherapy|October 14, 2010
Primary resistance to maraviroc in a large set of R5-V3 viral sequences from HIV-1-infected patientsEduardo Seclén, María del Mar González, Mariana Lapaz, et al.
Journal of Medical Virology|May 25, 2016
Long-term clinical experience with darunavir (2007-2015) in a large cohort of HIV-infected patients in SpainBerta Pernas, Marta Grandal, Andrés Tabernilla, et al.
AIDS (London, England)|May 29, 2004
Differences in disease progression in a cohort of long-term non-progressors after more than 16 years of HIV-1 infectionBerta Rodés, Carlos Toro, Ellen Paxinos, et al.
The Journal of Antimicrobial Chemotherapy|March 6, 2009
Design and validation of new genotypic tools for easy and reliable estimation of HIV tropism before using CCR5 antagonistsEva Poveda, Eduardo Seclén, María del Mar González, et al.
European Journal of Gastroenterology & Hepatology|April 15, 2017
Short article: Viral dynamics among hepatitis C virus chronic infected patients during direct-acting antiviral agents therapy: impact for monitoring and optimizing treatment durationAndres Tabernilla, Marta Grandal, Berta Pernas, et al.
AIDS (London, England)|November 8, 2017
Initial treatment response among HIV subtype F infected patients who started antiretroviral therapy based on integrase inhibitorsPurificación Cid-Silva, Luis Margusino-Framiñán, Vanesa Balboa-Barreiro, et al.
Pageof 15

Showing results (81-90 of 149) with videos related to

Sort By:
Pageof 15
Antiviral Therapy|June 28, 2013
Very late relapse after discontinuation of antiviral therapy for chronic hepatitis CVincent Soriano, Eugenia Vispo, Carmen de Mendoza, et al.
Open Forum Infectious Diseases|September 8, 2018
High Prevalence of Late-Stage Disease in Newly Diagnosed Human Immunodeficiency Virus Patients in Sierra LeoneGeorge A Yendewa, Eva Poveda, Sulaiman Lakoh, et al.
HIV Medicine|March 2, 2022
Predictors of low-level HIV viraemia and virological failure in the era of integrase inhibitors: A Spanish nationwide cohortHortensia Álvarez, Marta Rava, Cristina Martínez, et al.
Antiviral Research|November 14, 2012
The changing face of hepatitis C in the new era of direct-acting antiviralsVincent Soriano, Pablo Labarga, Jose V Fernández-Montero, et al.
The Journal of Antimicrobial Chemotherapy|October 14, 2010
Primary resistance to maraviroc in a large set of R5-V3 viral sequences from HIV-1-infected patientsEduardo Seclén, María del Mar González, Mariana Lapaz, et al.
Journal of Medical Virology|May 25, 2016
Long-term clinical experience with darunavir (2007-2015) in a large cohort of HIV-infected patients in SpainBerta Pernas, Marta Grandal, Andrés Tabernilla, et al.
AIDS (London, England)|May 29, 2004
Differences in disease progression in a cohort of long-term non-progressors after more than 16 years of HIV-1 infectionBerta Rodés, Carlos Toro, Ellen Paxinos, et al.
The Journal of Antimicrobial Chemotherapy|March 6, 2009
Design and validation of new genotypic tools for easy and reliable estimation of HIV tropism before using CCR5 antagonistsEva Poveda, Eduardo Seclén, María del Mar González, et al.
European Journal of Gastroenterology & Hepatology|April 15, 2017
Short article: Viral dynamics among hepatitis C virus chronic infected patients during direct-acting antiviral agents therapy: impact for monitoring and optimizing treatment durationAndres Tabernilla, Marta Grandal, Berta Pernas, et al.
AIDS (London, England)|November 8, 2017
Initial treatment response among HIV subtype F infected patients who started antiretroviral therapy based on integrase inhibitorsPurificación Cid-Silva, Luis Margusino-Framiñán, Vanesa Balboa-Barreiro, et al.
Pageof 15